← Evidence map

ArticleCureus2026

Subsequent Treatments After Progression on Cyclin-Dependent Kinase 4/6 Inhibitors: A Review of the Evidence and a Real-World Data Perspective From Portuguese Hospitals.

Rita Freitas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Subsequent Treatments After Progression on Cyclin-Dependent Kinase 4/6 Inhibitors: A Review of the Evidence and a Real-World Data Perspective From Portuguese Hospitals. | OpenQuestion